Gen Re

Gen Re is one of the leading property/casualty and life/health reinsurers in the world, and is a Berkshire Hathaway Company.

[Gen Re @Gen_Re]

New blog: "PFAS Awareness and Concern Continues to Grow. Will the Litigation it Generates Do Likewise?" See recap of PFAS litigation in the U.S.
https://t.co/64MaYBrg2Y
#GeneralLiability #CommercialLines

[Gen Re @Gen_Re]

Insurers should consider several factors when retaining a forensic meteorologist for its claims investigations. Read our new blog for a better understanding of the specialty of forensic meteorology and its place in the claims process. https://t.co/v0OB0JaIlT
#InsuranceClaims

[Gen Re @Gen_Re]

New blog: "The Latest in Obstructive Sleep Apnea" Approximately 1 billion people across the globe are estimated to have #ObstructiveSleepApnea, the most common respiratory-related sleep disorder. Read overview: https://t.co/m9XztXqYUO
#DisabilityInsurance #InsuranceClaims

[Gen Re @Gen_Re]

New blog on foundry operations: A look at the challenges for property insurers. We cover foundry technologies, hazards, protective measures, and key underwriting considerations when insuring foundries. https://t.co/nviVIkXcvU
#underwriting #firerisk #propertyinsurance

[Gen Re @Gen_Re]

New blog: "Medicare Supplement Market Keeps Evolving – Overview of Latest Survey" Mixed results for the market for 2023. See details including the role of #AcceleratedUnderwriting. https://t.co/Ule5rgexMG

[Gen Re @Gen_Re]

Our recent Insurance Claims Fraud Surveys obtained data from dozens of companies that offer a variety of Life, Health, and Disability products. Canada survey result released today: https://t.co/S6oYCC0vM0
#fraudprevention #insurancefraud #FraudWeek

[Gen Re @Gen_Re]

New blog: "The Risk and Challenges of Foreign Death Investigations"
Considerations for Life Claims professionals in your claims processes. https://t.co/kB2J9QZT76
#fraudprevention #insurancefraud #FraudWeek #InternationalFraudAwarenessWeek

[Gen Re @Gen_Re]

Phthalates are widely used in consumer and healthcare products – and so, an emerging health concern. Read regulations, recent litigation, and potential insurance implications with risks associated with phthalates exposure claims. https://t.co/YE4qbMbDau
#GeneralLiability

[Gen Re @Gen_Re]

New blog: "Alzheimer’s Disease Overview – Detection and New Treatments"
New treatments show promise in slowing Alzheimer’s in early stages. Read the overview and emerging treatment’s challenges and potential impact. https://t.co/TvFllr5QZB
#alzheimers #dementia #LifeInsurance

[Gen Re @Gen_Re]

Critical illness insurance rarely covers mental health disorders despite their significant impact. We explore key elements of defining severe schizophrenia as a covered condition and how Insurers can reduce stigma. https://t.co/a0egV9UCRu
#CriticalIllnessInsurance #MentalHealth

[Gen Re @Gen_Re]

New blog: "The Hidden Costs of Convenience - The Impact of Food Delivery Apps on Auto Accidents"
https://t.co/H0OlUQvBQY
#AutoInsurance #GeneralLiability #CommercialLines #CommercialUmbrella

[Gen Re @Gen_Re]

The use of #cannabis as a medical treatment continues to grow. We discuss various studies on the effectiveness of cannabis for certain conditions, and the importance of evidence-based risk frameworks for underwriters. https://t.co/vJ85KwQ5vO
#insurancerisk #medicalunderwriting

[Gen Re @Gen_Re]

New blog: "Focus Groups and Shadow Juries – Telling a Persuasive Story for Trial". P&C Claims Executives explain how the effort and expense of engaging focus groups could be useful in trial prep, with shadow juries during trial. https://t.co/LdMCk47VO2
#ClaimsManagement

[Gen Re @Gen_Re]

New blog: Gearing Up for #GroupTermLife Peak Season - when Evidence of Insurability applications are on the rise. For some companies, 75% of annual applications are received and processed during “peak season”. Main challenges and underwriting suggestions: https://t.co/b3oXPUdXGW

[Gen Re @Gen_Re]

New blog: "PFAS – Rougher Waters Ahead?"
A look at #PFAS pervasiveness and suspected health impact, legal and regulatory developments, and perspective as to how insurers should respond to this growing threat.
https://t.co/5aHLUuZ4FB
#GeneralLiability #CommercialLines

[Gen Re @Gen_Re]

New blog: "Key Takeaways From Our U.S. Claims Fraud Survey". In the U.S. alone, #InsuranceFraud is estimated to cost the industry approximately $308.6 billion per year. See a snapshot of findings from Gen Re’s 2024 U.S. Insurance Claims Fraud Survey. https://t.co/uNopTmV3bt

[Gen Re @Gen_Re]

#MultipleSclerosis is one of the most common neurologic conditions in young adults. New medications have been approved for treatment within the past few years, and symptoms can be managed. An update for Life & Health Disability Claims. https://t.co/EBEsxbi3HK
#disabilityinsurance

[Gen Re @Gen_Re]

The leading causes of Critical Illness claims are cancer, heart attacks, and strokes. A higher BMI is linked to an increased risk of cardiovascular disease (CVD) and insurance plays a key role in promoting healthier living.
https://t.co/bmbXOd5ndK
#critialillness #insuranceclaims

[Gen Re @Gen_Re]

Gen Re's Protection Pulse H1 2024 Update is out. IP and the WOL markets showed encouraging growth but demand in the Term and CI markets continued to reduce.
https://t.co/lhtvRQ6QiO
#ProtectionPulse #IncomeProtection #CriticalIllness

[Gen Re @Gen_Re]

Are GLP-1 analogues, such as semaglutide, presenting a breakthrough in weight loss medication? We describe the latest weight loss medications, study results, known risks, and current risk assessment guidelines. https://t.co/UYNuLmdKcV
#obesity #medicalunderwriting